Press Release
AMDeC Facilitates Agreement with RainDance Technologies to provide RDT1000 access to the Tri-Institutional Research Program of Memorial Sloan-Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medical College
Technology will be available to all of AMDeC's 28 member institutions as part of its technology access program
NEW YORK, February 22, 2010 – AMDeC, the Academy for Medical Development and Collaboration, announced today that RainDance Technologies will provide access to the RDT 1000 sequence enrichment platform with the Tri-Institutional Research Program. The acquisition resulted from a jointly submitted proposal from MSKCC's Genome Core Laboratory, The Rockefeller University's Genome Resource Center, and Weill Cornell Medical College's Genomics Core. When operational, the instrument will be available for use by AMDeC's membership of 28 biomedical research institutes in New York. AMDeC spearheaded the technology acquisition through the organization's vendor partnership agreement with RainDance Technologies
Beginning March 2010, researchers statewide will have access to the cutting-edge technology, which greatly accelerates enrichment of targeted portions of the human genome before processing on next generation sequencing platforms. The instrument was placed via AMDeC's technology access program, which provides consortium-wide access to emerging technologies after an AMDeC facilitated Request for Proposal (RFP).
“AMDeC continues at the forefront of leading scientific collaboration across New York's great academic institutions by providing technology access that many research institutes want but cannot afford on their own,” said Maria Mitchell, Ph.D., president and CEO of AMDeC. “Like the innovative nature of RainDance's signature RainStorm technology, AMDeC's pioneering approach to team science and groundbreaking efforts for academic access are exemplified through this agreement.”
The proposal submitted by the Tri-Institutional Research Program was among many others submitted by AMDeC member institutions to the RFP. The proposals were evaluated by RainDance and peer-reviewed by researchers outside of the AMDeC membership. The application reflected the best scientific applications and a solid plan for making the technology broadly available to AMDeC's members.
“We are very excited for the opportunity to partner with AMDeC and its member institutions.” said Roopom Banerjee, President and Chief Executive Officer of RainDance Technologies. “The RainStorm™ technology, when combined with the current Next Generation Sequencing Technologies, offers Industry leading performance for targeted DNA re-sequencing. This partnership with the exceptional scientific minds at the AMDeC member institutions, along with the proven enrichment quality of our flagship RDT 1000 product, will certainly accelerate breakthrough discoveries in genomic research.” “The AmDeC announcement follows closely on co-marketing partnerships that RainDance announced last week with Life Technologies and Pacific Biosciences,” Banerjee said. “We continue to be very active in partnering with leading customers and next-generation sequencing companies to advance the science of human healthcare.”
About RainDance Technologies
RainDance Technologies is pioneering the use of high-throughput microdroplet-based analysis in human health and life science research. The company's core RainStorm™ technology generates millions of discrete droplets that can encapsulate a single molecule, cell or reaction and be digitally analyzed and sorted one at a time. The power, precision and simplicity of microdroplets enable researchers to answer complex questions with unprecedented sensitivity and quantitation. The complete RainDance solution includes automated instrumentation, customizable bioinformatics and high-value consumables and reagents for applications including targeted next-generation DNA sequencing, methylation, digital PCR and single cell analysis. Based in Lexington, Massachusetts, the company supports scientists around the world through its international sales and support operations and a global network of distributors and service providers. For more information, please visit www.RainDanceTech.com.
RainDance, RainStorm, ThunderStorm, Digital Biology are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.
For technical questions contact:
James Brayer
RainDance Technologies
44 Hartwell Avenue
Lexington, MA 02421
781-861-6300
info@raindancetech.com
For press inquiries:
Colin Sanford
203-340-2441
colin@bioscribe.com
